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A B S T R A C T
Many studies have revealed that ascorbic acid (Aa) acts as a powerful inhibitor of genetic damage. The objetive
of the present study was to evaluate the radioprotector effect of Aa at two diferent radiation dose rates. The
somatic mutation and recombination test in Drosophila melanogaster was used. 48 h larvae were treated for 24 h
with 25, 50 and 100mM of Aa. After pretreatment, larvae were irradiated with 20 Gy of gamma rays ad-
ministered at 36 or 960 Gy/h. Toxicity, development rate and frequency of mutant spots were recorded. Results
provide evidence of a radioprotective effect for all tested concentrations of Aa only when 20 Gy were delivered at
36 Gy/h and only with 25mM using the 960 Gy/h. To consider the use of Aa as radioprotector or therapeutic
agent, it is necessary to know its potential under different situations to avoid unwanted injuries.
1. Introduction
The harmful effects of ionizing radiation in biologicalsystems are
produced essentially through direct deposition of energy into crucial
molecules (direct effect), or through the intracellular generation of
reactive oxygen species (ROS) including superoxide anion, hydrogen
peroxide, hydroxyl radicals, peroxide radicals, and other free radicals
(Azzam et al., 2012). The most common reactive ROS include super-
oxide anion (O2), hydrogen peroxide (H2O2) and hydroxyl radicals
(OH). At low levels, ROS show beneficial effects: they participate in
cellular response and immunity (Selim et al., 2016), but its excess
provokes different effects including lipid peroxidation, removal of thiol
groups from cellular and membrane proteins, strand breaks and base
alterations leading to DNA damage (Shukla et al., 2010). Free radicals
produce single and double DNA strand breaks, which lead to mutations.
Nowadays, it is well known that DNA damage plays a significant role in
the development of atherosclerosis and other degenerative diseases
including some kind of autism, Alzheimer, Parkinson and cancer
(Jones, 2010; Mirończuk-Chodakowska et al., 2018; Sanz, 2016). The
risk of injury from radiation is a function of the doses received; the type
of radiation (low or high linear energy transfer), the type of cell and
dose rate, among others (Kelsey et al., 2014). Dose rate is defined as the
radiation dose absorbed per unit of time (Ślosarek et al., 2014).
Nowadays, the extensive use of radiation for medical treatment,
diagnosis; its use in the energy sector, industry, nuclear accidents,
nuclear terrorism and in some other activities such as outer space or air
traveling, has increased the necessity to identify, develop, and validate
potential strategies to protect normal tissues from the harmful effects of
ionizing radiation (Singh and Krishnan, 2015). Pharmacological inter-
vention could be the most prudent strategy, given that compounds,
especially those of natural origin that can act as free radical scavengers
and antioxidants, are able to reduce or mitigate the deleterious effects
of ionizing radiation (Maurya et al., 2006).
Radioprotective agents are chemical compounds that reduce the
effects of radiation in healthy tissues and have been used to reduce
morbidity or mortality produced by ionizing radiation (Greenberger,
2009), they also have a practical use in clinical radiotherapy because
normal tissues should be protected against radiation injury while can-
cerous tissues are exposed to higher doses of radiation to obtain better
results. A large number of compounds showed good radioprotection in
in vitro studies, but most of them failed in vivo application due to acute
toxicity and side effects (Weiss and Landauer, 2003). There have been
many attempts to find an ideal radioprotector that can preferentially
protect normal tissues from radiation damage without affecting the
sensitivity of tumor cells (Bump and Malaker, 1997). The chemicals
that can scavenge free radicals reduce the occurrence of DNA strand
breaks. Thus they can prevent the formation of free radicals or destroy
free radicals by reacting with them, thereby inhibiting their reaction
with biomolecules. Since free radicals are short-lived, it is necessary for
such radioprotective molecules to be present in the cellular media at the
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time of radiation exposure.
To keep the damage caused by ROS from occurring, eukaryotic cells
possess antioxidant systems, such as enzymes that prevent or limit the
free radical production: superoxide dismutase, catalase, and glu-
tathione peroxidase. These enzymes provide important protection
against radiation exposure (Pisoschi and Pop, 2015). Besides the en-
zymes, the cell can prevent the free radical damage by means of dietary
antioxidants, including vitamins A, C, and E, polyphenols, anthocya-
nins, flavonoids and isothiocyanates (Weiss and Landauer, 2003;
Meyers et al., 2008).
Vitamin C is the reduced form of ascorbic acid (Aa), it is a water-
soluble ketolactone with two ionizable hydroxyl groups that readily
undergoes two consecutive one-electron oxidations to form the poorly
reactive ascorbate radical and the dehydroascorbic acid (Du et al.,
2012). Administration of Aa before gamma irradiation prevents chro-
mosomal damage in bone marrow cells and radiation-induced lethality
(Konopacka et al., 1998). The protective properties of this compound
are due mainly to its scavenging activity of reactive oxygen species
before they reach macromolecules, protecting lipid membranes and
proteins from oxidative damage (Berger et al., 1997). It has been re-
ported that Aa can prevent the adverse effects of whole body irradiation
through increasing the antioxidant defense systems in the liver and
kidney of irradiated animals (Mortazavi et al., 2015). Pretreatment with
Aa inhibits lipid peroxidation, protects mice against mortality and
sickness induced by irradiation, and produces an improvement of
wound healing after exposure to whole body gamma radiation (Prasad
et al., 2002).
Different factors modify the effect of Aa, the most studied are the
concentration and the presence of transition metals (Halliwell, 1999),
several experiments have shown that high concentrations of Aa in-
creased DNA damage through the production of hydroxyl radicals from
hydrogen peroxide by the Fenton reaction. Du et al. (2012) found that
pharmacological doses of ascorbate induce cytotoxicity and oxidative
stress in pancreatic cancer cells, but not in normal cells. Several studies
have revealed that Aa, can also have prooxidant effects (Halliwell,
1996); in fact, the combination of transition metals (such as Fe and Cu)
with ascorbate has long been used as an oxidizing system, and the
combination of these two reagents also known as the “unfriend system”
is used for the hydroxylation of alkanes, aromatics, and other oxida-
tions (Odin, 1997; Halliwell, 1999; Cai et al., 2001; Mendes-da-Silva
et al., 2014).
Although different experiments have been conducted to determine
the radioprotective effect of ascorbic acid, results are not consistent so
it is essential to explore under what circumstances antioxidants can
decrease or increase the genetic damage caused by ionizing radiation.
One of the factors modifying the effect of ionizing radiation is the dose
rate which is very important in radiotherapy, that is why the main
objective of the present work is to evaluate the radio protective effect of
Aa using two different dose rates by means of the somatic mutation and
recombination test (SMART) in the wing blade of Drosophila.
Since Drosophila is a holometabolous organism, toxicity can be as-
sessed in the different developmental stages: embryo, larval, pupal, and
adult. Various parameters such as: toxicity, development rate and ge-
netic damage could be tested using the same individuals, under which
circumstances antioxidants can protect from damage induced by io-
nizing radiation or increases it. From a radiobiological point of view, it
is known that mitotic recombination is inducible by radiation and its
significance in human oncogenesis is remarkable, the Drosophila
SMART test offers the great advantage of strongly identifying this ge-
netic point. Therefore, D. melanogaster could bring an essential con-
tribution to the antimutagenic and radio protection field.
2. Material and methods
Biological material and pretreatment: Three-day-old virgin mwh/
mwh females were mated to flr3/TM3 Ser males in 250ml flasks with
regular food. Oviposition was restricted to 2 h to obtain homogeneous
samples. Eggs were incubated in the culture room for 72 h to obtain
second instar larvae that were separated from the culture medium by
means of gradient density using a 20% sucrose solution. Larvae were
treated for 24 h in empty bottles containing a disc of filter paper and
3.5 ml of 0, 25, 50 and 100mM of Aa solution, using distilled water as
solvent. Aa concentrations, treatment period as well as genetic damage-
inducing dose were selected based on previous work in our laboratory
(Olvera et al., 1995, 1997; Cruces et al., 2003, 2009).
Treatment with radiation: After Aa pretreatment, larvae for each
concentration were divided in three groups: the first was irradiated
with 20 Gy at low DR (LDR): 36 Gy/h in the Gamma-Cell 2000 irra-
diator, the second at high DR (HDR): 960 Gy/h in the Transelektro LGI-
01 irradiator, and the third group was used as control. 1000 larvae were
tested for each treatment in groups of 100 by homeopathic vial with
0.8 g of synthetic medium (Formula 4–24 Carolina Biological Supply
Co.) and 2.5ml of distilled water. All treated larvae were introduced
into the culture room. After larvae completed their development, the
number of emerged adults, males and females separately, were re-
corded daily.
Developmental rate and larvae-to-adult viability analysis: Larvae-to-
adult developmental rate was determined by counting every day the
number of emerged flies, until all had emerged, larvae-to-adult survival
was measured as the ratio of the total number of emerged flies and
toxicity was obtained by dividing total viable adults into the number of
treated larvae. Once that data was obtained, survival curves were
constructed. The slope (m) of the exponential phase of each curve was
calculated for the development rate index and the emergence day for
50% of the individuals was determined by extrapolating the X axis. The
Chi square test was used to establish differences between treatments.
Genotoxicity analysis: The wings of the subsequently emerged
adults were mounted on slides following the standard procedure de-
scribed by Graf et al. (1984). The wings were scored at 40x magnifi-
cation for abnormal wing hair spots in small singles (1 or 2 cells), large
(more than 3 cells) either mwh or flr and twin spots. Single mwh spots
are inferred to arise from a separation between mwh and flr3, from an
interchange or from mutation/deletion at the mwh+ locus; single flr
spots occur from mutation/deletion at the flr+ locus or following a
double exchange; and twin spots from an interchange between flr and
the centromere. The frequencies of each type of mutant clones per wing
(s/p) were compared with the concurrent negative control.
Statistical analysis: The Chi-square test was used to identify statis-
tical differences in larvae-to-adult survival between control and the
remaining groups and to determine differences between genetic da-
mage caused by different treatments.
3. Results
Developmental rate and larvae-viability analysis: Table 1 shows
viability of second instar larvae treated with Aa 25, 50 or 100mM, none
of them decreased viability, however, in combination with 20 Gy at a
HDR 50 and 100mM they reduced the viability although no significant
differences were found. Fig. 1 represents the development rate of the
organisms treated with different concentrations of Aa and its treatment
combined with 20 Gy gamma rays administered at two different dose
rates. No differences were found between the slopes of the different
treatments and the control groups.
Genotoxicity analysis: Table 2 shows the frequency of all kinds of
spots (small, large, twin and total) produced by the treatment with the
three Aa concentrations and in combination with 20 Gy of gamma rays
administered at low or high dose ratios. None of the Aa concentrations
modified the basal frequency of mutations, 20 Gy of gamma rays ad-
ministered at 36 Gy/h, provoked an increase of 11.7 times in the total
spots over the basal frequency. The lowest concentration of Aa com-
bined with gamma rays reduced the frequencies of spots induced by
20 Gy: the small in 40%; the large in 20% and the total in 23%. The
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combined treatment of 50mM Aa+20 Gy reduced 68% the small, 32%
the large, 63% the twin and 49% the total spots, and the combined
treatment 100mM Aa+20 Gy reduced 35% the small, 31% the large,
20% the twin and 29% the total spots.
The HDR (960 Gy/ h) increased 19 times the basal frequency of
mutations (from 0.31 to 5.93) and provoked a significant diminution in
genetic damage in combination with 25mM of Aa in all kind of spots
(p≤ 0.001, 0.02 and 0.05 for small, single and twin spots respectively).
No concentration relationship with Aa was found neither with the low
nor with the HDR.
4. Discussion
Although radioprotection studies started 50 years ago, and several
compound have been screened for their radio protective capacity, the
practical applicability of the majority of these synthetic compounds has
remained limited, due to their toxicity at their optimum protective dose
(Prasad et al., 2002) and nowadays the use of natural compounds seems
to be the most favorable choice.
Dietary antioxidants are widely used as dietary supplements; many
studies suggested that these might promote health (Rahal et al., 2014).
Aa has been reported to be an effective antioxidant and free radical
scavenger in in vivo and in vitro conditions, it reduces oxidative and free
radical-induced damage to DNA and membranes in biological systems
(Halliwell, 2006). It has been demonstrated that treatment with Aa has
also significantly reduced the genotoxicity of well-known mutagens
(Odin, 1997) and it is considered to be a dietary radioprotective agent
due to its action as a reactive oxygen scavenger (Du et al., 2012). Most
studies have shown that vitamin C either reduces oxidative DNA da-
mage or has a null effect, whereas some reviews have shown an in-
crease in specific base lesions (Putchala et al., 2013).
In the present study it was found that the 24h-pretreatment with Aa,
did not cause changes in the development rate (m) with any of the Aa
concentrations or in combination with the two DR (Fig. 1). A non-sta-
tistical significant decrease in larva-to-adult viability was observed with
50 and 100mM of Aa in combination with the HDR, and a minimum
delay in development rate was observed when controls were compared
against the two DR. Based on the fact that DR is one of the physical
factors that modify the cellular response to radiation (Brooks et al.,
2016), the results of the present study showed that the DR has im-
portant implications for genetics and radioprotection. In radiobiology it
is assumed that doses administered at a LDR produce a less significant
biological effect because the cell can repair the damage. Narra et al.
(1993) found a greater radioprotective effect of Aa in mice spermatozoa
when Iodine-131 was incorporated than when radiation was adminis-
tered in acute form. A possible explanation for our results is that at a
HDR, greater the amount of free radicals and Aa is unable to inactivate
even at higher concentrations. Electromagnetic ionizing radiation in-
duces damage primarily through free radicals (Hiscock, 1999). The
radioprotective effect of Aa has been ascribed to its interactions with
radiation-induced free radicals (Mathew et al., 2007). Then the basis for
this research is that, Aa can stabilize the free radicals donating one of
their electrons and in this way prevent them from causing damage to
the molecules. No antioxidant has an effect on the direct effect of io-
nizing radiation.
Fujii et al. (2010) reported that in normal human fibroblast cells, Aa
treatment enhanced cell survival after been irradiated with X-rays, but
not after heavy ions irradiation. They concluded that Aa treatment is
not powerful enough to protect complex type of DNA damage induced
by heavy ions. Although the same type of radiation was used in this
report, some authors have suggested that HDR caused damage by
means of direct effect, which cannot be avoided by the action of anti-
oxidants and DNA double strand breaks (DSBs) are the most important
type of damage provoked.
The results of this study provide evidence of the protective capacity
of Aa against radiation damage induced at LDR probably as a sy-
nergistic effect with endogenous antioxidants capable of acting and / or
being induced to these levels of DR. Yang et al. (2017) found that the
administration of vitamin C increased the activity of oxidative enzymes
SOD and CAT which reduced ROS concentration on cells on Pichia
caribbica. Using Drosophila it was reported that DJ-1β mutant flies
treated with α-tocopherol or vitamin C exhibited a significant increase
in catalase activity compared with untreated individuals which was
accompanied with a decrease in ROS levels (Casani et al., 2013).
Our results show that only when 20 Gy was administered at a HDR
larvae-adult viability diminished, (although no statistical significant
differences were found), we can suggest that the absence of protection
of Aa in combination with the HDR was probably a consequence of Aa
toxicity (13.5% and 11.8% with 50 and 100mM respectively) added
with a higher amount of free radicals induced by the HDR in compar-
ison with those produced by the same dose of gamma rays but at a LDR.
So DR plays a central role in the effect of Aa. So for the authors the
effect might be due to the DR.
Therefore, further experiments are required to determine the con-
ditions under which Aa can protect healthy cells. The results obtained
in the present study enhance the necessity to test the different situations
Table 1
Viability percentage of second instar larvae treated with Aa and 20 Gy of
gamma rays at two different DR.
Treatment
Aa (mM)
No. of larvae No. Adults.
± SEM
Viability %
0 1000 907 ± 2.4 90.7
25 1000 880 ± 3.2 88.0
50 1000 838 ± 1.6 83.8
100 1000 826 ± 5.2 82.6
Low Dose Rate (36 Gy/h)
20 Gy 1000 888 ± 2.1 88.8
25+ 1000 841 ± 1.8 84.1
50+ 1000 834 ± 1.8 83.4
100+ 1000 816 ± 3.3 81.6
High Dose Rate (960 Gy/h)
20 Gy 1000 858 ± 3.6 85.8
25+ 1000 815 ± 1.1 81.5
50+ 1000 784 ± 1.0 78.4
100+ 1000 799 ± 1.7 79.9
The table presents three sections: the first one refers to the larvae-viability in-
duced by the Aa at the three tested concentrations; the second section refers to
the effect of Aa against a low DR and the third section against a high DR. +:
refers to treatment, plus 20 Gy at the corresponding DR.
Fig. 1. Development rate (m) of the organism treated with Aa and 20 Gy of
gamma rays at two different DR.
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in which Aa can be used: external or internal exposure, acute high-dose
radiation in contrast to chronic exposure, etc. To avoid an increase in
genetic damage provoked by radiation, it has been suggested the use of
antioxidants to protect healthy cells of patients receiving radiotherapy
as a treatment for cancer.
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